Edwards Lifesciences (EW) Other Working Capital Changes (2009 - 2026)

Edwards Lifesciences' Other Working Capital Changes history runs 18 years deep, the most recent figure standing at $18.1 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 36.71% year-over-year to $18.1 million in Q1 2026; TTM through Mar 2026 was $24.0 million, a 47.6% decrease from a year earlier, with the FY2025 full-year figure at $34.5 million, up 61.21% from the prior year.
• Other Working Capital Changes improved to $18.1 million in Q1 2026 per EW's latest filing, from $2.7 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $23.8 million in Q1 2023 and bottomed at -$27.1 million in Q1 2024.
• The 5-year median for Other Working Capital Changes is $8.7 million (2026), against an average of $5.4 million.
• Across the five-year window, Other Working Capital Changes jumped 12400.0% in 2022 and plunged 622.22% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $12.3 million in 2022, then sank by 126.02% to -$3.2 million in 2023, then surged by 640.62% to $17.3 million in 2024, then tumbled by 84.39% to $2.7 million in 2025, then jumped by 570.37% to $18.1 million in 2026.
• Per Business Quant, the three latest EW Other Working Capital Changes figures stand at $18.1 million (Q1 2026), $2.7 million (Q4 2025), and $7.9 million (Q3 2025).